MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 05-23-2026
Burning Rock Biotech Limited Operating Cycle 2011-2026 | BNR
Annual Operating Cycle Burning Rock Biotech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 245 | 245 | 289 | 318 | 308 | 274 | 140 | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 318 | 140 | 260 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
161 | $ 115.84 | 0.68 % | $ 35.2 B | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 7.3 | -19.87 % | $ 9.71 M | USA |
 |
Castle Biosciences
CSTL
|
97.4 | $ 21.26 | 7.97 % | $ 616 M | USA |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Fulgent Genetics
FLGT
|
87 | $ 17.9 | 1.3 % | $ 551 M | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
128 | $ 127.51 | 6.39 % | $ 16 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.16 | 2.88 % | $ 1.18 B | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 1.8 | - | $ 7.96 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
70.3 | $ 118.45 | 4.04 % | $ 9.77 B |  Irlanda |
 |
Illumina
ILMN
|
198 | $ 150.17 | 3.41 % | $ 23.9 B | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
121 | $ 99.09 | -0.97 % | $ 6.69 B | USA |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 093.84 | -0.68 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
65 | $ 164.49 | 4.95 % | $ 8.15 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
102 | $ 9.57 | 3.24 % | $ 1.23 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 428.0 | -0.26 % | $ 12.3 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 19.13 | 0.47 % | $ 428 M | USA |
 |
Natera
NTRA
|
81.5 | $ 203.11 | 1.1 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 3.94 | 2.34 % | $ 365 M | USA |
 |
Personalis
PSNL
|
63.8 | $ 9.49 | 6.15 % | $ 847 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.6 | -1.26 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
104 | $ 6.32 | -1.71 % | $ 264 M | USA |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
1.04 K | - | - | $ 2.69 B | USA |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 64.17 | -1.08 % | $ 3.84 B | USA |
 |
Biomerica
BMRA
|
204 | $ 2.46 | -0.61 % | $ 5.65 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 258.25 | -0.08 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 456.21 | 1.79 % | $ 172 B | USA |
 |
Waters Corporation
WAT
|
834 | $ 342.18 | 1.05 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.68 | 5.04 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
213 | $ 9.2 | 0.66 % | $ 2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 193.99 | 0.58 % | $ 21.5 B | USA |